Vadodara-based maker of mineral excipients & specialty ingredients for pharma/nutrition; entering battery-grade iron phosphate.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 1 | 1 | 1 | 1 | 10 | 10 | 11 |
| Reserves | 80 | 115 | 167 | 333 | 418 | 715 | 775 |
| Borrowings | 20 | 31 | 73 | 60 | 123 | 143 | 127 |
| Other Liabilities | 30 | 67 | 92 | 56 | 54 | 121 | 61 |
| Total Liabilities | 131 | 214 | 333 | 451 | 604 | 988 | 974 |
| AssetsFixed Assets | 60 | 68 | 120 | 96 | 105 | 299 | 102 |
| CWIP | 8 | 23 | 4 | 44 | 88 | 126 | 161 |
| Investments | 6 | 24 | 15 | 29 | 32 | 0 | 32 |
| Other Assets | 57 | 99 | 194 | 282 | 380 | 562 | 679 |
| Total Assets | 131 | 214 | 333 | 451 | 604 | 988 | 974 |
| Line item | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 10 | 36 | -5 | 59 | 59 | 96 |
| Cash from Investing | -22 | -45 | -28 | -41 | -92 | -367 |
| Cash from Financing | 12 | 13 | 40 | -16 | 54 | 242 |
| SummaryCapital Expenditure | — | — | — | — | — | — |
| Free Cash Flow | 1 | 24 | -62 | 27 | -2 | 30 |
| FCF Margin | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (52.3×) and current (75.8×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 10% growth and a 52× exit, ₹825 only delivers your return if you pay ₹392. The price is currently baking in 26% growth.
EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 52×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 10.0% | 11.98 |
| FY28 | 10.0% | 13.18 |
| FY29 | 10.0% | 14.49 |
| FY30 | 10.0% | 15.94 |
| FY31 | 10.0% | 17.54 |
| FY32 | 8.0% ·fade | 18.94 |
| FY33 | 6.0% ·fade | 20.08 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.